Your browser doesn't support javascript.
loading
Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region.
Bijker, Rimke; Choi, Jun Yong; Ditangco, Rossana; Kiertiburanakul, Sasisopin; Lee, Man Po; Siwamogsatham, Sarawut; Pujari, Sanjay; Ross, Jeremy; Wong, Chi-Yuen; Wong, Wing-Wai; Yunihastuti, Evy; Law, Matthew.
Afiliação
  • Bijker R; The Kirby Institute, UNSW, Sydney, NSW 2052, Australia.
  • Choi JY; Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Ditangco R; Research Institute for Tropical Medicine, Manila, Philippines.
  • Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Lee MP; Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Siwamogsatham S; King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Pujari S; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Ross J; Institute of Infectious Diseases, Pune, India.
  • Wong CY; TREAT Asia, Bangkok, Thailand.
  • Wong WW; Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Yunihastuti E; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Law M; Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Open AIDS J ; 11: 52-66, 2017.
Article em En | MEDLINE | ID: mdl-29302277
ABSTRACT

INTRODUCTION:

Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. MATERIALS AND

METHODS:

We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region.

RESULTS:

Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope.

CONCLUSION:

Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIV-positive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Open AIDS J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Open AIDS J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália